GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
10.16
-0.22 (-2.12%)
At close: May 12, 2025, 4:00 PM
9.50
-0.66 (-6.50%)
After-hours: May 12, 2025, 4:44 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $630.21 million as of May 12, 2025. Its market cap has increased by 9.32% in one year.
Market Cap
630.21M
Enterprise Value
315.53M
1-Year Change
9.32%
Ranking
Category
Stock Price
$10.16
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $630.21M, a decrease of -22.04%. That is a compound annual growth rate of -6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 643.85M | 76.79% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |